|
시장보고서
상품코드
1566765
면역혈액학 시장 : 제품별, 용도별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)Immunohematology Market By Product (Analyzers and Systems, Reagents) , By Application (Blood-related Diseases, HIV, Others) By End User (Hospitals, Diagnostic Laboratories, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033 |
||||||
세계 면역혈액학 시장은 2023년 19억 달러로 평가되며, 2024-2033년 연평균 4.6% 성장하여 2033년에는 30억 달러에 달할 것으로 예상됩니다.
혈액은행 또는 수혈 의학으로도 알려진 면역혈액학은 수혈과 관련된 혈액형 및 항체 연구에 초점을 맞춘 시험 의학의 전문 분야입니다. 적혈구 표면에 존재하는 혈액형 항원과 혈장에 존재하는 해당 항체의 식별 및 특성 분석을 수행합니다. 면역혈액학의 주요 목적은 기증자의 혈액형과 수혜자의 혈액형을 일치시키고 부작용을 방지하여 안전하고 적합한 수혈을 보장하는 것입니다. 이 분야는 수혈 요법, 장기 이식 및 다양한 혈액 질환의 관리에 중요한 역할을 합니다.
세계 면역혈액학 시장의 성장을 주도하고 있는 것은 만성질환의 유병률 증가와 수술 건수의 급격한 증가로 인해 안전한 수혈에 필수적인 정확한 혈액형 판별과 교차 매칭의 필요성이 크게 증가하고 있습니다. 또한, 고령화로 인해 빈혈, 백혈병 등의 발병률이 높아지면서 면역혈액학 제품에 대한 수요가 더욱 증가하고 있습니다. 또한, 혈액 안전과 기증자 적합성에 대한 인식이 높아지고 엄격한 규제가 강화되면서 면역혈액학 시장의 성장에 기여하고 있습니다.
그러나 첨단 면역 혈액 검사 장비와 시약은 고가의 비용으로 인해 특히 의료 예산이 부족한 개발도상국에서는 도입이 제한적일 수 있습니다. 반면, 자동화된 디지털 혈액 검사 플랫폼의 도입은 진단 정확도와 효율성을 향상시켜 신속하고 신뢰할 수 있는 혈액형 판정 및 교차 매칭에 대한 수요 증가에 대응할 수 있는 큰 잠재력을 가지고 있습니다. 예를 들어, 2023년 5월 Bio-Rad Laboratories, Inc.는 ID 카드용 완전 자동화 시스템인 IH-500TM NEXT 시스템 출시를 발표했으며, IH-500 NEXT 시스템은 Bio-Rad의 ID-Card와 함께 사용되어 일상적인 검사(유형별 및 스크리닝)과 단일 항원 판정 및 신생아 스크리닝을 포함한 특수 검사 모두에 대한 광범위한 포트폴리오를 제공합니다.
세분화 개요
세계 면역혈액학 시장은 제품, 응용 분야, 최종사용자 및 지역으로 분류됩니다. 제품을 기준으로 시장은 분석 장비 및 시스템 및 시약으로 분류됩니다. 용도별로 시장은 혈액 관련 질환, HIV 및 기타로 분류됩니다. 최종사용자에 따라 병원, 진단 실험실, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분류됩니다.
주요 조사 결과
제품별로는 시약 부문이 2023년 시장에서 가장 높은 점유율을 차지했습니다.
용도별로는 혈액 관련 질환 부문이 2023년 가장 큰 점유율을 차지했습니다.
최종사용자별로는 병원 부문이 2023년 가장 큰 점유율을 차지했습니다.
지역별로는 북미가 2023년 세계 면역혈액학 시장을 장악했습니다.
경쟁 시나리오
이 보고서는 사용자 정의가 가능합니다.
- 규제 가이드라인
- 고객의 관심사에 따른 기업 프로파일 추가
- 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
- 기업 개요 확대 목록
- 과거 시장 데이터
- 주요 진입기업 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)
목차
제1장 소개
제2장 주요 요약
제3장 시장 상황
- 시장 정의와 범위
- 주요 조사 결과
- 주요 투자 기회
- 주요 성공 전략
- Porter's Five Forces 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
제4장 면역혈액학 시장 : 제품별
- 시장 개요
- 분석기와 시스템
- 시약
제5장 면역혈액학 시장 : 용도별
- 시장 개요
- 혈액 관련 질환
- HIV 감염증
- 기타
제6장 면역혈액학 시장 : 최종사용자별
- 시장 개요
- 병원
- 진단 실험실
- 기타
제7장 면역혈액학 시장 : 지역별
- 시장 개요
- 북미
- 주요 시장 동향과 기회
- 미국의 면역혈액학 시장
- 캐나다의 면역혈액학 시장
- 멕시코의 면역혈액학 시장
- 유럽
- 주요 시장 동향과 기회
- 독일의 면역혈액학 시장
- 프랑스의 면역혈액학 시장
- 영국의 면역혈액학 시장
- 이탈리아의 면역혈액학 시장
- 스페인의 면역혈액학 시장
- 기타 유럽 면역혈액학 시장
- 아시아태평양
- 주요 시장 동향과 기회
- 일본의 면역혈액학 시장
- 중국의 면역혈액학 시장
- 인도의 면역혈액학 시장
- 호주의 면역혈액학 시장
- 한국의 면역혈액학 시장
- 기타 아시아태평양의 면역혈액학 시장
- 라틴아메리카, 중동 및 아프리카
- 주요 시장 동향과 기회
- 브라질의 면역혈액학 시장
- 사우디아라비아의 면역혈액학 시장
- 남아프리카공화국의 면역혈액학 시장
- 기타 라틴아메리카, 중동 및 아프리카의 국가의 면역혈액학 시장
제8장 경쟁 상황
- 소개
- 주요 성공 전략
- 주요 10개 기업 제품 매핑
- 경쟁 대시보드
- 경쟁 히트맵
- 주요 기업의 포지셔닝(2023년)
제9장 기업 개요
- Bio-Rad Laboratories, Inc
- Werfen
- Grifols, S.A.
- Danaher Corporation
- Siemens
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Cardinal Health
The global immunohematology market was valued at $1.9 billion in 2023, and is projected to reach $3.0 billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
Immunohematology, also known as blood banking or transfusion medicine, is a specialized branch of laboratory medicine that focuses on the study of blood groups and antibodies associated with blood transfusion. It involves the identification and characterization of blood group antigens on the surface of red blood cells and the corresponding antibodies present in plasma. The main goal of immunohematology is to ensure safe and compatible blood transfusions by matching the blood type of the donor with that of the recipient to prevent adverse reactions. This field plays a crucial role in transfusion therapy, organ transplantation, and managing various hematologic disorders.
The growth of the global immunohematology market is driven by rise in the prevalence of chronic diseases and surge in the number of surgical procedures, which have significantly boosted the need for accurate blood typing and cross-matching, which are crucial for safe transfusion practices. In addition, aging population has led to a higher incidence of conditions such as anemia and leukemia, further escalating the demand for immunohematology products. Moreover, rise in awareness and stringent regulations regarding blood safety and donor compatibility are contributing to the expansion of immunohematology market growth.
However, high cost associated with advanced immunohematology instruments and reagents, which can limit their adoption, especially in developing regions with limited healthcare budgets. On the other hand, adoption of automated and digital blood testing platforms offers significant potential for improving diagnostic accuracy and efficiency, catering to the growing demand for rapid and reliable blood typing and cross-matching. For instance, in May 2023, Bio-Rad Laboratories, Inc. announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. The IH-500 NEXT System is used with Bio-Rad's ID-Cards, offering a broad portfolio for both routine testing (type and screen) and specialized testing, including single antigen determination and newborn screening.
Segmentation Overview
The global immunohematology market is segmented into product, application, end user, and region. Depending on the product, the market is categorized into analyzers & systems and reagents. By application, it is classified into blood-related diseases, HIV, and others. According to end user, the market is divided into hospitals, diagnostic Laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the reagents segment held the highest share in the market in 2023.
Depending on the application, the blood-related diseases segment accounted for the maximum market share in 2023.
According to end user, the hospitals segment was the largest shareholder in 2023.
Region wise, North America dominated the global immunohematology market in 2023.
Competitive Scenario
The major players operating in the immunohematology market include Bio-Rad Laboratories, Inc, Werfen, Grifols, S.A., Danaher Corporation, Siemens, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, and Cardinal Health. These players have adopted several tactics such as product advancement & diversification, mergers & acquisitions, partnerships, collaborations, and advertising to strengthen their position in the competitive environment.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- Analyzers and Systems
- Reagents
By Application
- Blood-related Diseases
- HIV
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- Bio-Rad Laboratories, Inc
- Werfen
- Grifols, S.A.
- Danaher Corporation
- Siemens
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Cardinal Health
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: IMMUNOHEMATOLOGY MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Analyzers And Systems
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Reagents
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
CHAPTER 5: IMMUNOHEMATOLOGY MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Blood-related Diseases
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. HIV
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
CHAPTER 6: IMMUNOHEMATOLOGY MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Diagnostic Laboratories
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
CHAPTER 7: IMMUNOHEMATOLOGY MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Immunohematology Market
- 7.2.6.1. Market Size and Forecast, By Product
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Immunohematology Market
- 7.2.7.1. Market Size and Forecast, By Product
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Immunohematology Market
- 7.2.8.1. Market Size and Forecast, By Product
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Immunohematology Market
- 7.3.6.1. Market Size and Forecast, By Product
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Immunohematology Market
- 7.3.7.1. Market Size and Forecast, By Product
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Immunohematology Market
- 7.3.8.1. Market Size and Forecast, By Product
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Immunohematology Market
- 7.3.9.1. Market Size and Forecast, By Product
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Immunohematology Market
- 7.3.10.1. Market Size and Forecast, By Product
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe Immunohematology Market
- 7.3.11.1. Market Size and Forecast, By Product
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Immunohematology Market
- 7.4.6.1. Market Size and Forecast, By Product
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Immunohematology Market
- 7.4.7.1. Market Size and Forecast, By Product
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Immunohematology Market
- 7.4.8.1. Market Size and Forecast, By Product
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia Immunohematology Market
- 7.4.9.1. Market Size and Forecast, By Product
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Immunohematology Market
- 7.4.10.1. Market Size and Forecast, By Product
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Immunohematology Market
- 7.4.11.1. Market Size and Forecast, By Product
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Immunohematology Market
- 7.5.6.1. Market Size and Forecast, By Product
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Immunohematology Market
- 7.5.7.1. Market Size and Forecast, By Product
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Immunohematology Market
- 7.5.8.1. Market Size and Forecast, By Product
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Immunohematology Market
- 7.5.9.1. Market Size and Forecast, By Product
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
- 9.1. Bio-Rad Laboratories, Inc
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Werfen
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Grifols, S.A.
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Danaher Corporation
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Siemens
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Thermo Fisher Scientific Inc.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Abbott Laboratories
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Merck KGaA
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. F. Hoffmann-La Roche Ltd
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Cardinal Health
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
